All Type of News
KFDA unveils drug re-evaluation results
The Korea Food and Drug Administration announced on March 26 that it will retract its approval for problematic 14 generic drugs in terms of bioequivalence, banning pharmaceutical companies from manufacturing and selli...
Wholesalers to step up efforts against illegal foreign takeover bids
The Korean Association of Pharmaceutical Wholesaler (KAPW), a body representing interests of wholesalers, says that it will step up efforts to help protect management control of domestic firms from undue takeover bids...
Civil groups to ask for cheaper access to Glivec
11 civic groups in Korea have called for the National Health Insurance Corporation to lower the current price for Glivec of Swiss maker by 37.5 percent, ahead of the negotiation deadline (April 6) between the NHIC and...
4 human placenta supplies to be withdrawn from market
Four injectable preparations of human placenta extract will be excluded from the market due to the least efficacy, it was announced on March 26.
According to the announcement of the Korea Food and Drug Administrati...
KFDA opens patent information Web site for 70 blockbuster medicines
The Korea Food and Drug Administration said on March 25 that it has introduced a drug patent information Web site (www.medipatent.kfda.go.kr) “Informetics” for domestic pharmaceutical firms to facilitate efforts of th...
Pharmaceutical industry struggling to find prosperity through good ethics
The Korea Pharmaceutical Manufacturers Association is aimed at promoting free and fair competition by revising the current guidelines.
Critics say the guidelines in Korea have served as measuring reference in the m...
Combined sales of 74 drugmakers top 9.3 trillion won in 2008
The combined sales of 74 Korean pharmaceutical companies and 82 pharmaceutical wholesalers last year marked 9.3 trillion won and 6.2 trillion won, respectively, according to the Korea Tax Union.
Pharmaceutical firm...
Daewoong eyes price hike of Bease
Daewoong Pharm is considering a price hike of Bease, an OTC digestive, following the expected price increase of Ursa from next month.
A spokesperson for the company said, "We are considering another price increase....
KRPIA publishes green handbook for fair competition code
The Korean Research based Pharmaceutical Industry Association (KRPIA) says it has distributed its own guidebook to its member companies in a bid to let them understand the working guideline
The KRPIA has fostered ...
Prices of 124 lipid-lowering agents to be reduced by 15%
The Ministry of Health, Welfare and Family Affairs released on March 23 the results of its economic feasibility assessment on cholesterol-lowering drugs, as part of the government's efforts to lower drug costs.
The...
